Work-site hypertension prevalence and control in three Central European countries

Journal of Human Hypertension

Volumn 18, Issue 8, 2004, Pages 581-585

  Fodor, J G ^a   Lietava, J ^b   Rieder, A ^c   Sonkodi, S ^d   Stokes, H ^a   Emmons, T ^a   Turton, P ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b Second Medical Clinic   (Slovakia)

^c UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Blood pressure; Central Europe; Cerebrovascular stroke; Environmental factors

Indexed keywords

ADULT; ARTICLE; AUSTRIA; BLOOD PRESSURE MEASUREMENT; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE CONTROL; EMPLOYEE; ERROR; EUROPE; FEMALE; HEALTH SURVEY; HUMAN; HUNGARY; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OCCUPATIONAL DISEASE; POPULATION RESEARCH; PREVALENCE; REPRODUCIBILITY; SLOVAKIA; SPHYGMOMANOMETER; STANDARDIZATION; STROKE; WORKPLACE;

ADULT; ANTIHYPERTENSIVE AGENTS; AUSTRIA; BLOOD PRESSURE DETERMINATION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HUNGARY; HYPERTENSION; MALE; MASS SCREENING; OCCUPATIONAL HEALTH SERVICES; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SLOVAKIA; WORKPLACE;

EID: 4444279086     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001685     Document Type: Article

References (13)

1. McKee M, Shkolnikov V. Understanding the toll of premature deaths among men in Eastern Europe. Br Med J 2001; 323: 1051-1055.
2. Statistics Canada. Canadian statistics information. Accessed May 2002. Available from: URL: http://www.acdi.cida.gc.ca.
3. World Health Organization, Regional Office for Europe. European health for all database. Accessed January 2002. Available from: URL: http://www.who.dk/hfadb.
4. Kannel WB. Blood pressure as a cardiovascular risk factor. JAMA 1996; 275: 1571.
5. MacMahon S et al. Blood pressure, stroke, coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765.
6. Dahlöf B, Devereux RB, Kjeldsen SE. Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002; 359: 995-1003.
7. Wright JM, Mattu GS. Validation of a new algorithm for the BPM-100 electronic blood pressure monitor. Blood Pressure Monit 2001; 6: 161-165.
8. Ginter E. Cardiovascular risk factors in the former communist countries: Analysis of 40 European MONICA populations. Eur J Epidemiol 1995; 11: 199-205.
9. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomized trials. Lancet 2000; 355: 1955-1964.
10. Joffres M et al. Awareness, treatment and control of hypertension in Canada. Am J Hypertens 1997; 10: 1097-1102.
11. Kesteloot H. Regional differences in mortality: a comparison between Austria, Hungary and Switzerland. Acta Cardiol 1999; 54: 299-309.
12. Mark L, Kondacs A, Hanyecz V. Cardiovascular risk factor profile: Comparison of a Hungarian community with Germany. Wien Klin Wochenschr 1997; 109: 683-687.
13. Assmann G, Schulte H. The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J 1988; 116: 1713-1724.